Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
MaxCyte ( (MXCT) ) just unveiled an update.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. crossing a significant threshold in voting rights. The notification indicates that BlackRock now holds 7.76% of the voting rights in MaxCyte, reflecting a slight decrease from the previous 7.87%. This adjustment in holdings could have implications for MaxCyte’s governance and influence within the company, as BlackRock is a major player in the financial industry.
More about MaxCyte
YTD Price Performance: -41.51%
Average Trading Volume: 36,307
Technical Sentiment Signal: Strong Buy
Current Market Cap: £203.3M
For an in-depth examination of MXCT stock, go to TipRanks’ Stock Analysis page.